Financials

  • Market Capitalization 9.3387 B
  • Employee 711
  • Founded 2004
  • CEO Christopher Richard Anzalone
  • Website www.arrowheadpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRVKH0
  • Industry Technology
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3 449
市销率
5.56

Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

新闻